Battikhi M N G
Hashemite University, Faculty of Allied Health Sciences, Department of Medical Laboratory Sciences, Jordan.
New Microbiol. 2004 Jan;27(1):37-47.
This study was done to evaluate the occurrence of bloody diarrhoea in Jordan in the period 1988-2000, with particular interest in Shigilla and amoeba cases in relation to the surveillance control system and hygiene policy. The cases were collected from various medical diagnostic laboratories. In addition to the clinical presentation, stool specimens or rectal swabs were collected and sub-cultured on the appropriate media. Shigella spp. and amoeba were identified using standard methods. Anti-microbial susceptibility tests were performed. One-way ANOVA and Least Significant Difference (LSD) were used for statistical analysis. The number of stool specimens tested for bloody diarrhoea was 34,529 in the study period. Positive stool samples were reported in 711 (2.1%) patients. Out of these 55% were males and 45 % were females. The highest number of cases 96 (13.5%) was reported in the year 1999. The highest incidence rate was (20.6) in the year 1996 and the lowest incidence rate (8.9) was in the year 2000. The highest number of cases during the period 1998-1992 was among age group 1-4 year. During the year 1993-1996 the highest number of cases was among group 5-14 year. The highest number of cases during the year 1997-2000 was among age group 15-24 year. There was a significant variation between numbers of bloody diarrhoeal cases and age groups (P < 0.001) as well as sex (P = 0.028). No significant variation (P = 0.06) was observed between number of bloody diarrhoea cases and seasons or months. The number of stool specimens tested for amoebiasis during the study period 1994-2000 was 229,040. Shigella was isolated from 304(0.13%) cases and amoeba was found in 24,211(10.6%) cases. The lowest incidence rate in bloody diarrhoeal cases in the year 2000 indicates good quality hygienic control. The increased resistance of Shigella to antibiotics may produce a future problem, which might require a further prescribing policy for treatment.
本研究旨在评估1988 - 2000年期间约旦血性腹泻的发生情况,特别关注志贺氏菌和阿米巴病例与监测控制系统及卫生政策的关系。病例来自各个医学诊断实验室。除了临床表现外,还收集了粪便标本或直肠拭子,并在合适的培养基上进行传代培养。使用标准方法鉴定志贺氏菌属和阿米巴。进行了抗菌药敏试验。采用单因素方差分析和最小显著差法(LSD)进行统计分析。研究期间检测血性腹泻的粪便标本数量为34529份。711名(2.1%)患者的粪便样本呈阳性。其中55%为男性,45%为女性。1999年报告的病例数最多,为96例(13.5%)。1996年发病率最高,为(20.6),2000年发病率最低,为(8.9)。1998 - 1992年期间病例数最多的年龄组为1 - 4岁。1993 - 1996年期间病例数最多的年龄组为5 - 14岁。1997 - 2000年期间病例数最多的年龄组为15 - 24岁。血性腹泻病例数与年龄组(P < 0.001)以及性别(P = 0.028)之间存在显著差异。血性腹泻病例数与季节或月份之间未观察到显著差异(P = 0.06)。1994 - 2000年研究期间检测阿米巴病的粪便标本数量为229040份。从304例(0.13%)病例中分离出志贺氏菌,在24211例(10.6%)病例中发现阿米巴。2000年血性腹泻病例的最低发病率表明卫生控制质量良好。志贺氏菌对抗生素耐药性的增加可能会在未来产生问题,这可能需要进一步的治疗处方政策。